SURVIVAL OF PATIENTS WITH METASTATIC CANCER FOR MORE THAN THREE YEARS AFTER STARTING CONTINUOUS INFUSION IL-2 THERAPY IN TRIALS OF THE NATIONAL BIOTHERAPY STUDY GROUP (NBSG)

Publisher Website
Google Scholar
Abstract
No abstract available

This publication has 0 references indexed in Scilit: